Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress Pharmaceutical Investing
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results Life Science Investing
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week Life Science Investing
Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights Life Science Investing
Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates Life Science Investing
Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update Life Science Investing
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth Life Science Investing
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing Life Science Investing
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position Life Science Investing
